Development of Novel Therapeutics for the Treatment of Age-related Macular Degeneration.Leaderer, Derek.
Abstract: Age-related macular degeneration (AMD) is one of the most common causes of central vision loss among the elderly, yet treatment options remain extremely limited. The 'wet' form of AMD, characterized by choroidal neovascularization (CNV), is currently treated with repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents. However, intravitreal injections ar... read more
- Sackler School of Graduate Biomedical Sciences. Department of Genetics.
- Permanent URL
|To Cite:||DCA Citation Guide|